GRCL
Closed
Gracell Biotechnologies Inc.
10.25
+0.01 (+0.10%)
Last Update: 22 Feb 2024 17:30:00
Yesterday: 10.245
Day's Range: 10.25 - 10.25
Send
sign up or login to leave a comment!
When Written:
1.89
Gracell Biotechnologies Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing cell therapies for cancer treatment. The company was founded in 2017 and is headquartered in Shanghai, China, with additional offices in the United States and Singapore.
Gracell's proprietary platform, FasTCAR, is a next-generation CAR-T technology that enables the rapid development and manufacturing of cell therapies. The technology allows for the creation of CAR-T cells in just one day, compared to the several weeks required by traditional methods.
Gracell's pipeline includes several CAR-T cell therapies targeting various types of cancer, including acute myeloid leukemia, multiple myeloma, and solid tumors. The company has received funding from several investors, including Temasek, Lilly Asia Ventures, and King Star Capital.
In 2020, Gracell went public on the Nasdaq stock exchange, raising $100 million in its initial public offering (IPO). The company's market capitalization currently stands at around $3.5 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Gracell's proprietary platform, FasTCAR, is a next-generation CAR-T technology that enables the rapid development and manufacturing of cell therapies. The technology allows for the creation of CAR-T cells in just one day, compared to the several weeks required by traditional methods.
Gracell's pipeline includes several CAR-T cell therapies targeting various types of cancer, including acute myeloid leukemia, multiple myeloma, and solid tumors. The company has received funding from several investors, including Temasek, Lilly Asia Ventures, and King Star Capital.
In 2020, Gracell went public on the Nasdaq stock exchange, raising $100 million in its initial public offering (IPO). The company's market capitalization currently stands at around $3.5 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!